Last reviewed · How we verify
Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients (DEXsedation)
Dexmedetomidine, a central and peripheral α2-receptor agonist distinct from GABA receptor for benzodiazepines and propofol, has been approved by the US Food and Drug Administration only for use up to 24 h in mechanically ventilated patients. The investigators aim to compare dexmedetomidine with propofol for sedation \>24h in poly traumatized mechanically ventilated patients.
Details
| Lead sponsor | Assiut University |
|---|---|
| Phase | Phase 2/Phase 3 |
| Status | COMPLETED |
| Enrolment | 60 |
| Start date | 2015-11 |
| Completion | 2016-06 |
Conditions
- Trauma
Interventions
- Dexmedetomidine
- Propofol
Primary outcomes
- percentage of time with in the target sedation range of Richmond Agitation Sedation Scale-3-0 — 3 days
sedation goal is to maintain Richmond Agitation Sedation Scale from -3 up to 0
Countries
Egypt